Angelos M. Stergiou Sellas Life Sciences Group, Inc. (SLS) insider trading activity

Angelos M. Stergiou is President and CEO of SELLAS Life Sciences Group, Inc.. Currently has a direct ownership of 376,421 shares of SLS, which is worth approximately $447,940. The most recent transaction as insider was on Jan 22, 2024, when has been sold 159,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 376K

0% 3M change

71.34% 12M change

Total Value Held $447,940

Angelos M. Stergiou Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 22 2024	BUY Grant, award, or other acquisition	-	159,000 Added 29.7%	376,421 Common Stock
Dec 06 2023	SELL Other acquisition or disposition	$13,249 $1.08 p/Share	12,268 Reduced 5.34%	217,421 Class A Common Stock
Feb 02 2023	BUY Grant, award, or other acquisition	-	58,000 Added 20.89%	219,689 Common Stock
Dec 05 2022	SELL Open market or private sale	$16,949 $2.61 p/Share	6,494 Reduced 3.86%	161,689 Class A Common Stock
Jan 31 2022	BUY Grant, award, or other acquisition	-	44,000 Added 21.04%	165,167 Common Stock
Dec 02 2021	SELL Open market or private sale	$13,250 $6.25 p/Share	2,120 Reduced 1.72%	121,167 Common Stock
Mar 04 2021	BUY Grant, award, or other acquisition	-	19,750 Added 16.73%	98,287 Common Stock

AMS

Angelos M. Stergiou

President and CEO

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SLS shares.

Notify only if

Value

Insider Trading

Get notified when an Sellas Life Sciences Group, Inc. insider buys or sells SLS shares.

Notify only if

Operation

Value

Type

News

Receive news related to SELLAS Life Sciences Group, Inc.

Track Activities on SLS

Account